Neolight Secures $7M to Expand At-Home Jaundice Treatment

NeoLight, an innovative company focused on delivering advanced neonatal care technology into the home environment, has successfully secured an additional $7 million in funding.

This funding round saw participation from Dignity Health and Honor Health Systems, alongside continued support from existing investors including Pittsburgh Steelers quarterback Ben Roethlisberger and his wife, Ashley, as well as other investors who have chosen to remain anonymous. 

Originally developed for application within hospital settings, the company shifted its focus to offer its devices directly to new parents, a change driven by the increasing trend of early newborn discharge for quarantine purposes.

The company’s specialized light therapies are engineered to address conditions such as jaundice, a common ailment affecting approximately 60% of newborns and potentially causing brain damage if not properly addressed, as stated by the company.

“A key difficulty lies in the fact that a physician might not be able to determine the need for treatment until the infant is three or four days old, frequently after the baby has already been discharged from the hospital,” explained Vivek Kopparthi, the company’s founder, in a recent announcement.